98 related articles for article (PubMed ID: 3874685)
21. Associations between HLA-C alleles and papillary thyroid carcinoma.
Haghpanah V; Khalooghi K; Adabi K; Amiri P; Tavangar SM; Amirzargar A; Ghaffari H; Yazdani N; Nikbin B; Larijani B; Amoli MM
Cancer Biomark; 2009; 5(1):19-22. PubMed ID: 19242058
[TBL] [Abstract][Full Text] [Related]
22. The relation of susceptibility to and biologic behavior of thyroid epithelial cell cancer to HLA-DR1.
Juhasz F; Balázs G; Stenszky V; Kozma L; Farid NR
Cancer; 1986 Jul; 58(1):52-4. PubMed ID: 3486708
[TBL] [Abstract][Full Text] [Related]
23. [Immunohistochemical studies of mononuclear cellular infiltrates of papillary, follicular and anaplastic thyroid cancers].
Kornfehl J; Wilfing A; Hermann M
Laryngorhinootologie; 1994 Apr; 73(4):183-8. PubMed ID: 8011021
[TBL] [Abstract][Full Text] [Related]
24. Epitope-Specific Antitumor Immunity Suppresses Tumor Spread in Papillary Thyroid Cancer.
Ehlers M; Kuebart A; Hautzel H; Enczmann J; Reis AC; Haase M; Allelein S; Dringenberg T; Schmid C; Schott M
J Clin Endocrinol Metab; 2017 Jul; 102(7):2154-2161. PubMed ID: 27860539
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of HLA class II genes associated with disease susceptibility and progression in rheumatoid arthritis.
Heldt C; Listing J; Sözeri O; Bläsing F; Frischbutter S; Müller B
Arthritis Rheum; 2003 Oct; 48(10):2779-87. PubMed ID: 14558083
[TBL] [Abstract][Full Text] [Related]
26. Thyroid papillary carcinoma in HLA identical sibs.
Dzwonkowski P; O'Leary J; Farid NR
Lancet; 1988 Oct; 2(8617):971. PubMed ID: 2902423
[No Abstract] [Full Text] [Related]
27. Strong association of antiepithelial cell antibodies with HLA-DR3 or DR7 phenotype in patients with recurrent oral ulcers.
Sun A; Hsieh RP; Liu BY; Wang JT; Leu JS; Wu YC; Chiang CP
J Formos Med Assoc; 2000 Apr; 99(4):290-4. PubMed ID: 10870311
[TBL] [Abstract][Full Text] [Related]
28. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE).
Granados J; Vargas-Alarcón G; Drenkard C; Andrade F; Melín-Aldana H; Alcocer-Varela J; Alarcón-Segovia D
Lupus; 1997; 6(1):57-62. PubMed ID: 9116720
[TBL] [Abstract][Full Text] [Related]
29. HLA-DR typing in coeliac disease: evidence for genetic heterogeneity.
Ellis A; Taylor CJ; Dillon-Remmy M; Woodrow JC; McConnell RB
Br Med J (Clin Res Ed); 1984 Dec; 289(6458):1571-3. PubMed ID: 6439322
[TBL] [Abstract][Full Text] [Related]
30. Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma.
Lindhorst E; Schumm-Draeger PM; Bojunga J; Usadel KH; Herrmann G
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):27-31. PubMed ID: 11835122
[TBL] [Abstract][Full Text] [Related]
31. DR and non-DR Ia allotypes are associated with susceptibility to coeliac disease.
Corazza GR; Tabacchi P; Frisoni M; Prati C; Gasbarrini G
Gut; 1985 Nov; 26(11):1210-3. PubMed ID: 3877664
[TBL] [Abstract][Full Text] [Related]
32. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation.
Damiola F; Byrnes G; Moissonnier M; Pertesi M; Deltour I; Fillon A; Le Calvez-Kelm F; Tenet V; McKay-Chopin S; McKay JD; Malakhova I; Masyakin V; Cardis E; Lesueur F; Kesminiene A
Int J Cancer; 2014 Apr; 134(7):1659-68. PubMed ID: 24105688
[TBL] [Abstract][Full Text] [Related]
33. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
[TBL] [Abstract][Full Text] [Related]
34. HLA-DR7 in association with chlorpromazine-induced lupus anticoagulant (LA).
Vargas-Alarcón G; Yamamoto-Furusho JK; Zuñiga J; Canoso R; Granados J
J Autoimmun; 1997 Dec; 10(6):579-83. PubMed ID: 9451597
[TBL] [Abstract][Full Text] [Related]
35. HLA-DR7 in children with idiopathic nephrotic syndrome. Correlation with atopy.
de Mouzon-Cambon A; Bouissou F; Dutau G; Barthe P; Parra MT; Sevin A; Ohayon E
Tissue Antigens; 1981 May; 17(5):518-24. PubMed ID: 6950537
[TBL] [Abstract][Full Text] [Related]
36. Autoimmunity to native type II collagen--a distinct genetic subset of rheumatoid arthritis.
Klimiuk PS; Clague RB; Grennan DM; Dyer PA; Smeaton I; Harris R
J Rheumatol; 1985 Oct; 12(5):865-70. PubMed ID: 3878877
[TBL] [Abstract][Full Text] [Related]
37. [Class II HLA antigens and rheumatoid factors in rheumatoid polyarthritis. Inverse influence of DR4 and DR7 antigens?].
Cohen JH; Blanchard F; Vischer TL
Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):639-41. PubMed ID: 3497427
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR antigen frequencies in a North Indian type I diabetic population.
Bhatia E; Mehra NK; Taneja V; Vaidya MC; Ahuja MM
Diabetes; 1985 Jun; 34(6):565-7. PubMed ID: 3891468
[TBL] [Abstract][Full Text] [Related]
39. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.
Mallal S; Nolan D; Witt C; Masel G; Martin AM; Moore C; Sayer D; Castley A; Mamotte C; Maxwell D; James I; Christiansen FT
Lancet; 2002 Mar; 359(9308):727-32. PubMed ID: 11888582
[TBL] [Abstract][Full Text] [Related]
40. Further evidence for an association of HLA-DR7 with basal cell carcinoma on the tropical island of Saba.
Bavinck JN; Bastiaens MT; Marugg ME; Beckers RC; Westendorp RG; Vermeer BJ; Claas FH
Arch Dermatol; 2000 Aug; 136(8):1019-22. PubMed ID: 10926738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
